BioCryst Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BCRX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
24 Jun 24	SellUS$54,352	Amy McKee	Individual	8,600	US$6.32
17 Jun 24	SellUS$28,134	A. Sanders	Individual	4,689	US$6.00
14 Jun 24	SellUS$40,925	Theresa Heggie	Individual	6,698	US$6.11
30 May 24	BuyUS$49,996	Alan Levin	Individual	7,861	US$6.36
24 May 24	BuyUS$16,000	Stephen Aselage	Individual	2,500	US$6.40

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BCRX?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	2,182,913	1.04%
General Public	29,941,213	14.3%
Institutions	177,126,148	84.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 62.24% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.9%	BlackRock, Inc.	22,768,246	US$233.1m	3.05%	no data
10.4%	The Vanguard Group, Inc.	21,659,765	US$221.8m	-1.05%	no data
4.27%	Kynam Capital Management, LP	8,928,523	US$91.4m	-1.73%	8.07%
4.16%	Avoro Capital Advisors LLC	8,700,000	US$89.1m	-26.7%	1.43%
3.73%	State Street Global Advisors, Inc.	7,813,404	US$80.0m	4.19%	no data
2.87%	Alkeon Capital Management, LLC	6,004,000	US$61.5m	1.86%	0.38%
2.48%	Deerfield Management Company, L.P. Series C	5,189,665	US$53.1m	-36.3%	1.09%
2.37%	Geode Capital Management, LLC	4,960,637	US$50.8m	2.84%	no data
1.84%	Rp Management, Llc, Asset Management Arm	3,846,154	US$39.4m	0%	24.2%
1.82%	Millennium Management LLC	3,812,874	US$39.0m	383%	0.03%
1.62%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	3,398,474	US$34.8m	0%	0.01%
1.54%	Two Sigma Advisers, LP	3,220,712	US$33.0m	28.8%	0.07%
1.49%	Caligan Partners, LP	3,107,669	US$31.8m	3.73%	5.97%
1.46%	Fisher Asset Management, LLC	3,052,137	US$31.3m	-4.1%	0.01%
1.38%	GW&K Investment Management, LLC	2,884,680	US$29.5m	-1.93%	0.26%
1.34%	UBS Asset Management AG	2,804,297	US$28.7m	337%	no data
1.04%	Eversept Partners, L.P.	2,172,436	US$22.2m	9.7%	2.5%
1.03%	Jupiter Fund Management Plc	2,148,969	US$22.0m	82.4%	0.06%
0.98%	Two Sigma Investments, LP	2,045,535	US$20.9m	15.3%	0.04%
0.97%	Voloridge Investment Management, LLC	2,033,783	US$20.8m	28.7%	0.07%
0.97%	Rice Hall James & Associates, LLC	2,027,568	US$20.8m	-2.58%	1.16%
0.93%	Northern Trust Global Investments	1,955,258	US$20.0m	-2.48%	no data
0.93%	Morgan Stanley, Investment Banking and Brokerage Investments	1,952,916	US$20.0m	46.6%	no data
0.92%	Charles Schwab Investment Management, Inc.	1,922,038	US$19.7m	-2.93%	no data
0.88%	Stifel Asset Management Corp.	1,836,979	US$18.8m	-0.33%	0.02%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/19 14:38
End of Day Share Price	2025/05/19 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioCryst Pharmaceuticals, Inc. is covered by 30 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Huidong Wang	Barclays
Tazeen Ahmad	BofA Global Research
Dae Gon Ha	BTIG